Sunrise Detox Brentwood is a licensed substance use treatment provider in Brentwood, NY, listed in the SAMHSA treatment directory. Clients can live on site in a residential program while they complete treatment. On site detox services are available, so withdrawal can be managed before treatment begins. Buprenorphine (Suboxone) is offered to reduce opioid cravings and lower relapse and overdose risk. Naltrexone is used to support recovery from opioid or alcohol use disorder. Private health insurance is accepted. It serves young adults, adults, seniors.
Availability and current services change often. Call (888) 470-5244
and we will help you confirm openings, insurance, and next steps.
Buprenorphine used in TreatmentNaltrexone used in Treatment
Detox services
Alcohol DetoxificationBenzodiazepines DetoxificationCocaine DetoxificationMethamphetamines detoxificationOpioids detoxificationMedication routinely used during detoxification
Payment accepted
Federal military insurance (e.g., TRICARE)Private health insuranceCash or self-payment
Ages served
Young AdultsAdultsSeniors
Accreditation
State substance use treatment agencyCommission on Accreditation of Rehabilitation Facilities (CARF)The Joint CommissionDrug Enforcement Agency (DEA)
Free & confidential, 24/7
Not sure which program fits? Talk it through with someone who can help.
OutpatientOutpatient methadone/buprenorphine or naltrexone treatmentRegular outpatient treatmentFederal, or any government funding for substance use treatment programsMedicare
Residential/24-hour residentialLong-term residentialShort-term residentialFederal, or any government funding for substance use treatment programsMedicaid
OutpatientIntensive outpatient treatmentOutpatient methadone/buprenorphine or naltrexone treatmentFederal, or any government funding for substance use treatment programsIHS/Tribal/Urban (ITU) funds
998 Crooked Hill Road, 1st and 2nd Floors, Building 5, Brentwood, NY 11717
Residential/24-hour residentialLong-term residentialShort-term residentialFederal, or any government funding for substance use treatment programsMedicare